Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses

被引：33

作者：

Russell, Charles J. ^{[1
,2
]}

Hurwitz, Julia L. ^{[1
,2
]}

机构：

[1] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA

[2] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA

来源：

EXPERT REVIEW OF VACCINES | 2016年 / 15卷 / 02期

关键词：

Sendai virus; paramyxovirus; pediatric vaccine; respiratory tract; antibody; T cell; vaccine vector; intranasal; RESPIRATORY SYNCYTIAL VIRUS; AFRICAN-GREEN MONKEYS; M-PROTEIN BINDS; HUMAN PARAINFLUENZA; FUSION PROTEIN; COTTON RATS; NEUTRALIZING ANTIBODY; MEMBRANE-FUSION; B-CELL; PROTECTIVE IMMUNITY;

D O I：

10.1586/14760584.2016.1114418

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Human paramyxoviruses are the etiological agents for life-threatening respiratory virus infections of infants and young children. These viruses, including respiratory syncytial virus (RSV), the human parainfluenza viruses (hPIV1-4) and human metapneumovirus (hMPV), are responsible for millions of serious lower respiratory tract infections each year worldwide. There are currently no standard treatments and no licensed vaccines for any of these pathogens. Here we review research with which Sendai virus, a mouse parainfluenza virus type 1, is being advanced as a Jennerian vaccine for hPIV1 and as a backbone for RSV, hMPV and other hPIV vaccines for children.

引用

页码：189 / 200

页数：12

共 135 条

[51] Development of an AIDS vaccine using Sendai virus vectors [J].

Ishii, Hiroshi ;

Matano, Tetsuro .

VACCINE, 2015, 33 (45) :6061-6065

[52] STUDIES OF THE CONFORMATION-DEPENDENT NEUTRALIZING EPITOPES OF SIMIAN IMMUNODEFICIENCY VIRUS ENVELOPE PROTEIN [J].

JAVAHERIAN, K ;

LANGLOIS, AJ ;

MONTEFIORI, DC ;

KENT, KA ;

RYAN, KA ;

WYMAN, PD ;

STOTT, J ;

BOLOGNESI, DP ;

MURPHEYCORB, M ;

LAROSA, GJ .

JOURNAL OF VIROLOGY, 1994, 68 (04) :2624-2631

[53] Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children [J].

Jaye, A ;

Magnusen, AF ;

Sadiq, AD ;

Corrah, T ;

Whittle, HC .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (11) :1969-1977

[54] Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV [J].

Jones, Bart ;

Zhan, Xiaoyan ;

Mishin, Vasiliy ;

Slobod, Karen S. ;

Surman, Sherri ;

Russell, Charles J. ;

Portner, Allen ;

Hurwitz, Julia L. .

VACCINE, 2009, 27 (12) :1848-1857

[55] Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model [J].

Jones, Bart G. ;

Sealy, Robert E. ;

Surman, Sherri L. ;

Portner, Allen ;

Russell, Charles J. ;

Slobod, Karen S. ;

Dormitzer, Philip R. ;

DeVincenzo, John ;

Hurwitz, Julia L. .

VACCINE, 2014, 32 (26) :3264-3273

[56] Sendai virus-based RSV vaccine protects African green monkeys from RSV infection [J].

Jones, Bart G. ;

Sealy, Robert E. ;

Rudraraju, Rajeev ;

Traina-Dorge, Vicki L. ;

Finneyfrock, Brad ;

Cook, Anthony ;

Takimoto, Toru ;

Portner, Allen ;

Hurwitz, Julia L. .

VACCINE, 2012, 30 (05) :959-968

[57]

Karron R.A., 2007, FIELDS VIROLOGY, V1, P1497

[58] Live-Attenuated Respiratory Syncytial Virus Vaccines [J].

Karron, Ruth A. ;

Buchholz, Ursula J. ;

Collins, Peter L. .

CHALLENGES AND OPPORTUNITIES FOR RESPIRATORY SYNCYTIAL VIRUS VACCINES, 2013, 372 :259-284

[59] Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children [J].

Karron, Ruth A. ;

Thumar, Bhagvanji ;

Schappell, Elizabeth ;

Surman, Sonja ;

Murphy, Brian R. ;

Collins, Peter L. ;

Schmidt, Alexander C. .

VACCINE, 2012, 30 (26) :3975-3981

[60] Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the fusion protein gene [J].

Kato, A ;

Kiyotani, K ;

Hasan, MK ;

Shioda, T ;

Sakai, Y ;

Yoshida, T ;

Nagai, Y .

JOURNAL OF VIROLOGY, 1999, 73 (11) :9237-9246

← 1 2 3 4 5 6 7 8 9 10 →